Healthcare provider profile · identity verified

Kimberly Ann Ratcliffe, MD

Internal Medicine · NEWPORT NEWS, VA · NPI 1396706313

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	281	82
Levothyroxine Sodium	Levothyroxine Sodium	232	54
Omeprazole	Omeprazole	225	59
Metoprolol Succinate	Metoprolol Succinate	144	37
Amlodipine Besylate	Amlodipine Besylate	131	36
Losartan Potassium	Losartan Potassium	130	45
Lisinopril	Lisinopril	122	30
Escitalopram Oxalate	Escitalopram Oxalate	102	28
Gabapentin	Gabapentin	101	25
Rosuvastatin Calcium	Rosuvastatin Calcium	91	26
Metformin Hcl	Metformin Hcl	83	22
Potassium Chloride	Potassium Chloride	73	23
Simvastatin	Simvastatin	73	16
Hydrochlorothiazide	Hydrochlorothiazide	71	20
Alprazolam	Alprazolam	65	23
Furosemide	Furosemide	65	21
Pantoprazole Sodium	Pantoprazole Sodium	65	24
Tramadol Hcl	Tramadol Hcl	59	12
Albuterol Sulfate Hfa	Albuterol Sulfate	58	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	15
Meloxicam	Meloxicam	54	19
Sertraline Hcl	Sertraline Hcl	51	13
Glipizide Er	Glipizide	48	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	21
Ozempic	Semaglutide	47	suppressed
Prednisone	Prednisone	45	27
Alendronate Sodium	Alendronate Sodium	43	12
Citalopram Hbr	Citalopram Hydrobromide	43	11
Ezetimibe	Ezetimibe	43	15
Fluticasone Propionate	Fluticasone Propionate	41	19
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Trazodone Hcl	Trazodone Hcl	39	11
Lorazepam	Lorazepam	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	11
Famotidine	Famotidine	34	12
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Synthroid	Levothyroxine Sodium	32	12
Allopurinol	Allopurinol	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Azithromycin	Azithromycin	29	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	11
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Montelukast Sodium	Montelukast Sodium	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Carvedilol	Carvedilol	27	12
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Cephalexin	Cephalexin	24	17
Fluconazole	Fluconazole	24	15
Meclizine Hcl	Meclizine Hcl	24	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	22	suppressed
Movantik	Naloxegol Oxalate	22	suppressed
Nystatin	Nystatin	22	suppressed
Atenolol	Atenolol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	15
Januvia	Sitagliptin Phosphate	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Methylprednisolone	Methylprednisolone	19	15
Myrbetriq	Mirabegron	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Temazepam	Temazepam	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Glipizide	Glipizide	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Colesevelam Hcl	Colesevelam Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Amoxicillin	Amoxicillin	15	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Doxepin Hcl	Doxepin Hcl	15	suppressed
Eliquis	Apixaban	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Colchicine	Colchicine	14	suppressed
Diazepam	Diazepam	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Baclofen	Baclofen	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Finasteride	Finasteride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error